Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Endocrinology

Biology and Genetics: How the Adrenal Factory Works

At a Glance

Simple virilizing CAH is caused by an inherited CYP21A2 gene mutation that impairs the 21-hydroxylase enzyme. This prevents the adrenal glands from producing enough cortisol, causing an overproduction of androgens. It is typically diagnosed via newborn screening for high 17-OHP levels.

To understand 21-hydroxylase deficiency, it helps to think of the adrenal glands as a chemical factory. This factory uses a starting material (cholesterol) to create three essential products: cortisol (the stress hormone), aldosterone (the salt-balancing hormone), and androgens (male-type sex hormones) [1][2].

The Genetic “Blueprint”

The instructions for building the 21-hydroxylase enzyme are found in a gene called CYP21A2 [1][3]. In people with Congenital Adrenal Hyperplasia (CAH), this gene has a mutation that causes the enzyme to work poorly or not at all [3][4].

Because this is an autosomal recessive condition, a person must inherit a mutated copy of the gene from both parents to have the disorder [1][2].

The Biological Traffic Jam

When the 21-hydroxylase enzyme is missing or deficient, the production line in the adrenal factory gets “blocked.”

  1. Low Cortisol and Aldosterone Balancing: The body cannot finish making cortisol. In the severe salt-wasting form, aldosterone production is also completely blocked [5][6]. However, in the Simple Virilizing form, the body retains just enough enzyme activity to produce sufficient aldosterone for daily balance [4][7].
  2. The ACTH Feedback Loop: The brain (pituitary gland) notices the low cortisol and sends out a “work harder” signal called ACTH (adrenocorticotropic hormone) [8][9].
  3. Hormonal Diversion: Because the factory is still being told to work but the main “exit” for cortisol is blocked, the raw materials are diverted into the only open pathway—the one that makes androgens (like testosterone) [10][6][11].
  4. Adrenal Hyperplasia: The constant stimulation from ACTH causes the adrenal glands to grow larger (hyperplasia), which further increases the overproduction of androgens [8][12].

How Doctors Diagnose the Condition

Diagnosis often starts with Newborn Screening (NBS), which measures a hormone precursor called 17-hydroxyprogesterone (17-OHP) [13][14]. If the “factory” is blocked, 17-OHP builds up in the blood.

  • Initial Screening: Most states use an “immunoassay” to quickly screen 17-OHP levels [15].
  • Second-Tier Testing: To be more precise, doctors use a more advanced method called LC-MS/MS (liquid chromatography-tandem mass spectrometry). This test can measure multiple hormones at once, such as 21-deoxycortisol, which is a very specific marker for this condition [15][16][17].
  • Genetic Testing: Analyzing the CYP21A2 gene helps doctors confirm the diagnosis and predict whether the child will have a severe (salt-wasting) or moderate (simple virilizing) form [18][4].

Understanding “False” Results

Newborn screening is designed to be very sensitive so it doesn’t miss any cases, but this can lead to false positives (a positive result in a healthy baby) [19].

  • Prematurity: Premature or low-birth-weight babies naturally have higher 17-OHP levels, which can look like CAH [19][20].
  • Timing: If blood is drawn too soon after birth (precocious collection), it may lead to a false negative because the baby’s hormone levels haven’t stabilized yet [19].
  • Stress: A very sick or stressed newborn may also have temporary hormone elevations that are not related to CAH [19].

Doctors use birth weight and gestational age to adjust the “normal” range and minimize these false alarms [20].

Common questions in this guide

What causes simple virilizing CAH?
It is caused by an inherited mutation in the CYP21A2 gene. This mutation impairs the 21-hydroxylase enzyme, disrupting how the adrenal glands produce essential hormones like cortisol and androgens.
Why does CAH cause the adrenal glands to grow larger?
When the body cannot make enough cortisol, the brain continuously sends a signal called ACTH to stimulate the adrenal glands to work harder. This constant stimulation causes the glands to enlarge, a condition known as hyperplasia.
How is 21-hydroxylase deficiency diagnosed in babies?
Doctors typically diagnose the condition using a newborn screening blood test that measures a hormone called 17-OHP. If those initial levels are high, more specific blood tests like LC-MS/MS and genetic testing are used to confirm the diagnosis.
Can a newborn screening test for CAH be wrong?
Yes, newborn screening is highly sensitive and can result in false positives, especially in premature, low-birth-weight, or highly stressed babies. Drawing blood too soon after birth can also cause false negatives, which is why doctors adjust normal ranges based on birth weight and age.
What is the difference between simple virilizing and salt-wasting CAH?
Both forms involve a 21-hydroxylase deficiency. However, in the simple virilizing form, the body retains just enough enzyme activity to produce sufficient aldosterone to maintain a safe salt balance, whereas the severe salt-wasting form cannot.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my child's newborn screen result adjusted for their birth weight and gestational age?
  2. 2.Can you explain the specific 'second-tier' testing (like LC-MS/MS) that was used to confirm the diagnosis?
  3. 3.What specific mutation was found in the CYP21A2 gene, and what does that tell us about the severity of the condition?
  4. 4.If the 17-OHP level was high, were other hormones like 21-deoxycortisol also measured to be sure?
  5. 5.How often will we need to check hormone levels to ensure the 'feedback loop' with ACTH is well-managed?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    The spectrum of CYP21A2 gene mutations in patients with classic salt wasting form of 2l-hydroxylase deficiency in a Chinese cohort.

    Liu Y, Zheng J, Liu N, et al.

    Molecular genetics & genomic medicine 2020; (8(11)):e1501 doi:10.1002/mgg3.1501.

    PMID: 32959514
  2. 2

    Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.

    Parsa AA, New MI

    The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):2-11 doi:10.1016/j.jsbmb.2016.06.015.

    PMID: 27380651
  3. 3

    The experience of women living with Congenital Adrenal Hyperplasia: impact of the condition and the care given.

    Engberg H, Möller A, Hagenfeldt K, et al.

    Clinical endocrinology 2016; (85(1)):21-8 doi:10.1111/cen.13054.

    PMID: 26941069
  4. 4

    Genetic characterization of a large cohort of Argentine 21-hydroxylase Deficiency.

    Fernández CS, Taboas M, Bruque CD, et al.

    Clinical endocrinology 2020; (93(1)):19-27 doi:10.1111/cen.14190.

    PMID: 32289882
  5. 5

    Adrenal steroidogenesis and congenital adrenal hyperplasia.

    Turcu AF, Auchus RJ

    Endocrinology and metabolism clinics of North America 2015; (44(2)):275-96.

    PMID: 26038201
  6. 6

    Update on adrenal steroid hormone biosynthesis and clinical implications.

    Bacila IA, Elder C, Krone N

    Archives of disease in childhood 2019; (104(12)):1223-1228 doi:10.1136/archdischild-2017-313873.

    PMID: 31175123
  7. 7

    Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency.

    Grošelj U, Žerjav Tanšek M, Trebušak Podkrajšek K, et al.

    Acta chimica Slovenica 2016; (63(1)):33-7 doi:10.17344/acsi.2015.1797.

    PMID: 26970786
  8. 8

    MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis.

    Miller WL

    European journal of endocrinology 2018; (179(3)):R125-R141.

    PMID: 29880708
  9. 9

    Introduction: Contemporary perspectives on congenital adrenal hyperplasia: impacts on reproduction.

    New MI, Rosenwaks Z

    Fertility and sterility 2019; (111(1)):4-6 doi:10.1016/j.fertnstert.2018.11.031.

    PMID: 30611412
  10. 10

    Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment.

    Loli P, Menotti S, di Filippo L, Giustina A

    Endocrine 2025; (90(1)):1-16 doi:10.1007/s12020-025-04341-5.

    PMID: 40699527
  11. 11

    Classic and current concepts in adrenal steroidogenesis: a reappraisal.

    Kater CE, Giorgi RB, Costa-Barbosa FA

    Archives of endocrinology and metabolism 2022; (66(1)):77-87.

    PMID: 35263051
  12. 12

    Management challenges and therapeutic advances in congenital adrenal hyperplasia.

    Mallappa A, Merke DP

    Nature reviews. Endocrinology 2022; (18(6)):337-352 doi:10.1038/s41574-022-00655-w.

    PMID: 35411073
  13. 13

    Newborn Screening for CAH-Challenges and Opportunities.

    Heather NL, Nordenstrom A

    International journal of neonatal screening 2021; (7(1)) doi:10.3390/ijns7010011.

    PMID: 33668620
  14. 14

    Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.

    Cavarzere P, Camilot M, Palma L, et al.

    Hormone research in paediatrics 2022; (95(3)):255-263 doi:10.1159/000524170.

    PMID: 35350013
  15. 15

    Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand.

    de Hora MR, Heather NL, Patel T, et al.

    International journal of neonatal screening 2020; (6(1)):6.

    PMID: 33073005
  16. 16

    Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

    Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, et al.

    Endocrine reviews 2022; (43(1)):91-159 doi:10.1210/endrev/bnab016.

    PMID: 33961029
  17. 17

    Best Practice for Identification of Classical 21-Hydroxylase Deficiency Should Include 21 Deoxycortisol Analysis with Appropriate Isomeric Steroid Separation.

    Greaves RF, Kumar M, Mawad N, et al.

    International journal of neonatal screening 2023; (9(4)) doi:10.3390/ijns9040058.

    PMID: 37873849
  18. 18

    Issues with the Detection of Large Genomic Rearrangements in Molecular Diagnosis of 21-Hydroxylase Deficiency.

    Concolino P

    Molecular diagnosis & therapy 2019; (23(5)):563-567 doi:10.1007/s40291-019-00415-z.

    PMID: 31317337
  19. 19

    Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.

    Hayashi GY, Carvalho DF, de Miranda MC, et al.

    Clinical endocrinology 2017; (86(4)):480-487 doi:10.1111/cen.13292.

    PMID: 27978607
  20. 20

    Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.

    de Hora MR, Heather NL, Webster D, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(9)):e3390-e3399 doi:10.1210/clinem/dgab383.

    PMID: 34058748

This information about CAH genetics and biology is for educational purposes only. Always consult your pediatric endocrinologist or genetic counselor for medical advice and test interpretation.

Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.